香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 公告 豫園股份 截至 2025 年 6 月 30 日止六個月之 主要財務數據 於 2025 年 8 月 25 日，上 海豫 園 旅遊 商城（ 集團 ）股 份 有限 公 司（「 豫園股 份 」）， 復星 國 際 有 限公 司 （「 本公司 」）之 附 屬公 司 ，其 A 股 於上 海 證券 交 易所 上 市及 買 賣（ 股份 代 號：600655））刊 發 其 2025 年 半 年度 報 告（「該 報 告 」）。 本公 司 之董 事 會（「 董事會 」）謹 請 本公 司股 東 及公 眾 投資 者留 意 以下 有 關該 報告 所 載豫 園 股份 截至 2025 年 6 月 30 日止 六 個月 （「本 報 告 期 」）未 經審 計之 主 要財 務 數據 ： 單位：元 幣種：人民幣 | | 本報告期 | 上年同期 | 本報告期比上年 同期增減 1 (%) | | --- | --- | --- | --- | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 建議採納復星醫藥2025年A股期權計劃及 2025年H股受限制股份單位計劃 及 建議H股受限制股份單位首次授予 建議採納 2025 年 A 股期權計劃及 2025 年 H 股受限制股份單位計劃 於 2025 年 8 月 22 日，復星醫藥董事會決議批准建議採納 A 股期權計劃及 H 股受限制股份單位計劃。根據中國相關法律法規及 /或 香港上市規則，採 納 A 股期權計劃及 H 股受限制股份單位計劃須經復星醫藥股東於復星醫藥 股東會上審議及批准。 就 香港上市規則第 17 章而 言 ，復星醫藥構成本公司 的主要附屬公司，採納 H 股受限制股份單位計劃亦須經復星國際股東於本 公司 股 東大 會上審議及批准。 建 議 H 股受限制股份單位首次授予 於 2025 年 8 月 22 日，復星醫藥董事會建議於 H 股受限制股份單位計劃獲 採納後， 根 據 H 股受限制股份單位計劃 作 出 H 股受限制股份單位首次授 ...

Group 1 - The core point of the article is that Fosun International's subsidiary, Hainan Mining, has signed a capital increase agreement with Luoyang Fengrui Fluorine Industry Co., Ltd. and its existing shareholders [1] - Hainan Mining will invest RMB 300 million to subscribe for the newly registered capital of RMB 33.885 million, acquiring a 15.7895% stake in the target company post-capital increase [1] - This capital increase aligns with Hainan Mining's strategic focus on resource exploration, development, and operation, aiming to optimize its resource industry layout and enhance profitability [1]

Core Viewpoint - Fosun International (00656) announced an investment agreement where Hainan Mining, a subsidiary, will invest RMB 300 million to acquire a 15.7895% stake in Luoyang Fengrui Fluorine Industry Co., Ltd, aligning with its strategic focus on resource exploration and development [1] Group 1: Investment Details - Hainan Mining will subscribe to the newly registered capital of RMB 33.885 million in Luoyang Fengrui Fluorine Industry Co., Ltd [1] - The investment will be made in cash, totaling RMB 300 million [1] - After the completion of this investment, the company will indirectly hold 15.7895% of the target company's equity [1] Group 2: Strategic Implications - The investment aligns with Hainan Mining's strategic planning focused on the exploration, development, and operation of strategic resources [1] - This move is expected to optimize Hainan Mining's resource industry layout and enhance its profitability [1]

Core Viewpoint - Fosun International (00656) announced an investment in Luoyang Fengrui Fluorine Industry Co., Ltd. through its subsidiary Hainan Mining, acquiring a 15.7895% stake by investing RMB 300 million, which aligns with its strategic focus on resource exploration and development [1] Group 1 - Hainan Mining signed a capital increase agreement with existing shareholders of the target company, committing to invest RMB 300 million for an additional registered capital of RMB 33.885 million [1] - The investment will result in Hainan Mining indirectly holding 15.7895% of the target company's expanded equity after the capital increase [1] - This capital increase is part of Hainan Mining's strategic plan to optimize its resource industry layout and enhance profitability [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 由於本次增資之一項或多項適用百分比率（定義見上市規則第 14.04(9) 條）超過 5%但均低於 25%，本次增資構成上市規則第 14 章項下本公司之 須予披露交易，須遵守上市規則第 14 章項下之通知 及公告規定。 股東協議 項 下約定了海南礦業回購選擇權，該權利乃由海南礦業酌情決定 行使。根據上市規則第 14.75（ 1）條，就授出海南礦業回購選擇權 ，計算 相 關 適 用 百 分 比 率 時 將 僅 考 慮 溢 價 （ 為 零 ）。 本 公 司 將 於 海 南 礦 業 行 使 該 權利時遵守上市規則項下相關規定。 股東協議 項 下約定了目標公司與實際控制人回購選擇權，而該權利之行使 並非由本公司或海南礦業酌情決定，根據上市規則第 14.74（ 1）條，於授 出目標公司與實際控制人回購選擇權時，交易將予以分類猶如目標公司與 實際控制人回購選擇權已獲行使。經考慮目標公司與實際控制人回購選擇 權獲行使之 ...

格隆汇8月12日丨复星国际(00656.HK)宣布，董事会谨定于2025年8月27日（星期三）举行董事会会议， 藉以（其中包括）批准刊发本公司及其附属公司截至2025年6月30日止六个月的中期业绩，以及考虑派 发中期股息（如有）。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 承董事會命 復星國際有限公司 董事長 郭廣昌 2025年8月12日 於本公告日期，本公司之執行董事為郭廣昌先生、汪群斌先生、陳啟宇先生、徐曉亮先生、龔 平先生、黃震先生及潘東輝先生；非執行董事為李樹培先生、李富華先生及羅元澧先生；而獨 立非執行董事為章晟曼先生、張化橋先生、張彤先生、李開復博士及曾璟璇女士。 董事會會議召開日期 復星國際有限公司（「本公司」）董事會（「董事會」）茲通告謹定於 2025 年 8 月 27 日（星期三）舉行董事會會議，藉以（其中包括）批准刊發本公司及其附屬 公司截至 2025 年 6 月 30 日止六個月之中期業績，以及考慮派發中期股息（如 有）。 ...

Market Overview - The Hong Kong stock market showed mixed performance with the Hang Seng Index closing up 0.25% at 24,969.68 points and a total trading volume of HKD 215.42 billion [1] - The Hang Seng China Enterprises Index rose by 0.32% to 8,916.85 points, while the Hang Seng Tech Index fell by 0.38% to 5,439.16 points [1] Blue Chip Performance - Semiconductor company SMIC (00981) led the blue-chip stocks, rising 5.03% to HKD 51.15, contributing 17.41 points to the Hang Seng Index [2] - Other notable blue-chip performers included Zhongsheng Holdings (00881) up 4.01% and Orient Overseas International (00316) up 3.13% [2] Sector Highlights - Semiconductor stocks rebounded, with SMIC and Huahong Semiconductor both gaining over 5% [3] - The insurance sector saw significant gains, with China Pacific Insurance (02601) up 6.2% and New China Life Insurance (01336) up 3.86% [5][6] - Coal stocks were active, with China Shenhua Energy (01088) rising 3% and Yanzhou Coal Mining (01171) up 2.95% [6] Emerging Trends - The global semiconductor market is expected to continue its optimistic growth trajectory, driven by AI and domestic demand [4] - The dairy sector showed strong performance, with Aoyuan Group (02425) surging 43.15% [4] - The insurance industry is adjusting to a new regulatory environment, with a decrease in preset interest rates expected to lower costs for new business liabilities [6] Notable Stock Movements - Zhonghui Biotech (02627) surged 31.31% due to strong demand for its vaccine products [7] - Fosun International (00656) rose 13.3% following news of its application for a stablecoin license [8] - Chongqing Machinery (02722) announced a profit increase of approximately 50% for the first half of the year, leading to a 5.92% rise in its stock price [10] - Jin Sangzi (06896) experienced a significant drop of 23.64% due to a profit warning, anticipating a 37% decrease in profit compared to the previous year [11]

Market Overview - The Hong Kong stock market showed mixed performance, with the Hang Seng Index rising by 0.25% to close at 24,969.68 points, while the Hang Seng Tech Index fell by 0.38% to 5,439.16 points. The total trading volume was HKD 215.42 billion [1] - The outflow of funds from Hong Kong stocks is projected to reach nearly HKD 300 billion for the year, with an expected increase in southbound capital supply exceeding HKD 1.2 trillion [1] Blue Chip Performance - Semiconductor company SMIC (00981) led blue-chip gains, rising 5.03% to HKD 51.15, contributing 17.41 points to the Hang Seng Index. The company is expected to benefit from the domestic semiconductor substitution trend [2] - Other notable blue-chip movements included Zhongsheng Holdings (00881) up 4.01% and Orient Overseas International (00316) up 3.13%, while CSPC Pharmaceutical (01093) fell 3.09% [2] Sector Highlights - Chip stocks rebounded, with SMIC and Huahong Semiconductor both gaining over 5%. The semiconductor sector is expected to see continued growth driven by domestic demand and high capacity utilization [3][4] - Dairy stocks showed strong performance, with Aoyuan Group (02425) surging 43.15% and Modern Dairy (01117) rising 10.32%, benefiting from favorable market conditions [4][5] - The insurance sector saw significant gains, with China Pacific Insurance (02601) up 6.2% and New China Life Insurance (01336) up 3.86%, driven by a recent adjustment in the guaranteed interest rate for traditional insurance products [6] Notable Stock Movements - Zhonghui Biotech (02627) surged 31.31% as it focuses on vaccine development and had a highly oversubscribed IPO [7] - Fosun International (00656) rose 13.3% after confirming its application for a stablecoin license in Hong Kong [8] - Rare wine brand Zhenjiu Lid (06979) increased by 8.04%, with expectations of a market recovery in the liquor industry [9] - Chongqing Machinery (02722) announced a profit increase of approximately 50% for the first half of the year, leading to a 5.92% rise in its stock price [10] - Jin Sangzi (06896) experienced a significant drop of 23.64% due to a profit warning, anticipating a 37% decrease in profit compared to the previous year [11]